Search Results

Combination of nateglinide with thiazolidinediones in Type 2 diabetes

Authors: Voulgari, Christina; Tentolouris, Nicholas

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 6, November 2009 , pp. 537-552(16)

Publisher: Expert Reviews

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes

Authors: Derosa, G.; Tinelli, C.; Maffioli, P.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1091-1099(9)

Publisher: Blackwell Publishing

The backbone of oral glucose-lowering therapy: time for a paradigm shift?

Author: Seufert, Jochen

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 6, December 2009 , pp. 651-667(17)

Publisher: Blackwell Publishing

Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment

Authors: Garruti, Gabriella; Depalo, Raffaella; Vita, Maria Grazia; Lorusso, Filomenamila; Giampetruzzi, Federica; Damato, Aurelia Bellomo; Giorgino, Francesco

Source: Reproductive BioMedicine Online, Volume 19, Number 4, October 2009 , pp. 552-563(12)

Publisher: Reproductive Healthcare Ltd

Variability in MI incidence casts doubt on large trials

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 1-1(1)

Publisher: Adis International

Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone

Authors: Chapell, R.; Gould, A. L.; Alexander, C. M.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 11, November 2009 , pp. 1009-1016(8)

Publisher: Blackwell Publishing

Liraglutide: A Review of its Use in Type 2 Diabetes Mellitus

Authors: Croom, Katherine F.; McCormack, Paul L.

Source: Drugs, Volume 69, Number 14, 1 October 2009 , pp. 1985-2004(20)

Publisher: Adis International

Targeting insulin sensitivity in the treatment of polycystic ovary syndrome

Authors: Pasquali, Renato; Gambineri, Alessandra

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 10, October 2009 , pp. 1205-1226(22)

Publisher: Informa Healthcare

Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial - a primary care, type 2 diabetes study

Authors: Blonde; Dagogo-Jack; Banerji; Pratley; Marcellari; Braceras; Purkayastha; Baron

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 10, October 2009 , pp. 978-986(9)

Publisher: Blackwell Publishing

Impact of Diabetes and its Treatment on Bone

Author: Schwartz, Ann

Source: Clinical Review in Bone and Mineral Metabolism, Volume 7, Number 3, September 2009 , pp. 249-260(12)

Publisher: Humana Press

Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?

Authors: Papanas, N.; Maltezos, E.

Source: Current Pharmaceutical Design, Volume 15, Number 27, September 2009 , pp. 3179-3192(14)

Publisher: Bentham Science Publishers

The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

Authors: Katsiki, Niki; Georgiadou, Eleni; Hatzitolios, Apostolos I.

Source: Drugs, Volume 69, Number 11, July 30 2009 , pp. 1417-1431(15)

Publisher: Adis International

Thiazolidinediones and Cardiovascular Risk — A Question of Balance

Authors: Erdmann, Erland; Charbonnel, Bernard; Wilcox, Robert

Source: Current Cardiology Reviews, Volume 5, Number 3, August 2009 , pp. 155-165(11)

Publisher: Bentham Science Publishers

Liver Safety in Patients with Type 2 Diabetes Treated with Pioglitazone: Results from a 3-Year, Randomized, Comparator-Controlled Study in the US

Authors: Tolman, Keith G.; Freston, James W.; Kupfer, Stuart; Perez, Alfonso

Source: Drug Safety, Volume 32, Number 9, 1 September 2009 , pp. 787-800(14)

Publisher: Adis International

Improving cardiovascular risk - applying evidence-based medicine to glucose-lowering therapy with thiazolidinediones in patients with type 2 diabetes

Author: Fisher, M.

Source: International Journal of Clinical Practice, Volume 63, Number 9, September 2009 , pp. 1354-1368(15)

Publisher: Blackwell Publishing

Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan

Authors: Hsiao, Fei-Yuan; Huang, Weng-Foung; Wen, Yu-Wen; Chen, Pei-Fen; Kuo, Ken N.; Tsai, Yi-Wen

Source: Drug Safety, Volume 32, Number 8, 8 August 2009 , pp. 675-690(16)

Publisher: Adis International

Thiazolidinediones increase fracture risk in both sexes

Source: Reactions, Volume 1, Number 1260, 2009-07-11 , pp. 3-3(1)

Publisher: Adis International

Pharmacogenomics and the prevention of vascular complications in diabetes mellitus

Authors: Farbstein, Dan; Levy, Andrew P

Source: Therapy, Volume 6, Number 4, July 2009 , pp. 531-538(8)

Publisher: Future Medicine

NICE new guidelines for treating patients with T2DM

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 580, 2009-06-13 , pp. 3-3(1)

Publisher: Adis International

Risk of Fractures with Glitazones: A Critical Review of the Evidence to Date

Authors: Bodmer, Michael; Meier, Christian; Kraenzlin, Marius E.; Meier, Christoph R.

Source: Drug Safety, Volume 32, Number 7, 1 July 2009 , pp. 539-547(9)

Publisher: Adis International